<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33022226</PMID><DateCompleted><Year>2021</Year><Month>01</Month><Day>25</Day></DateCompleted><DateRevised><Year>2021</Year><Month>11</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-4199</ISSN><JournalIssue CitedMedium="Internet"><Volume>108</Volume><Issue>4</Issue><PubDate><Year>2020</Year><Month>Nov</Month><Day>25</Day></PubDate></JournalIssue><Title>Neuron</Title><ISOAbbreviation>Neuron</ISOAbbreviation></Journal><ArticleTitle>Survival and Motor Phenotypes in FVB C9-500 ALS/FTD BAC Transgenic Mice Reproduced by Multiple Labs.</ArticleTitle><Pagination><StartPage>784</StartPage><EndPage>796.e3</EndPage><MedlinePgn>784-796.e3</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.neuron.2020.09.009</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0896-6273(20)30709-1</ELocationID><Abstract><AbstractText>Mordes et&#xa0;al. (2020) did not detect the survival or motor phenotypes in C9orf72 BAC transgenic mice originally described by Liu et&#xa0;al. (2016). We discuss methodological differences between the Mordes and Liu studies, several additional studies in which survival and motor phenotypes were found, and possible environmental and genetic effects. First, Nguyen et&#xa0;al. (2020) showed robust ALS/FTD phenotypes in C9-BAC versus non-transgenic (NT) mice and that &#x3b1;-GA<sub>1</sub> treatment improved survival, behavior, and neurodegeneration. The groups of Gelbard and Saxena also show decreased survival of C9-BAC versus NT mice and neuropathological and behavioral deficits similar to those shown by Liu et&#xa0;al. (2016). Although FVB/N mice can have seizures, increases in seizure severity and death of C9 and NT animals, which may mask C9 disease phenotypes, have been observed in recent C9-500 FVB/NJ-bred cohorts. In summary, we provide an update on phenotypes seen in FVB C9-BAC mice and additional details to successfully use this model. This Matters Arising Response paper addresses the Mordes et al. (2020) Matters Arising paper, published concurrently in Neuron.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Lien</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Center for NeuroGenetics, Department of Molecular Genetics and Microbiology, College of Medicine, Genetics Institute, University of Florida, Gainesville, FL 32610, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laboissonniere</LastName><ForeName>Lauren A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Center for NeuroGenetics, Department of Molecular Genetics and Microbiology, College of Medicine, Genetics Institute, University of Florida, Gainesville, FL 32610, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Shu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center for NeuroGenetics, Department of Molecular Genetics and Microbiology, College of Medicine, Genetics Institute, University of Florida, Gainesville, FL 32610, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pilotto</LastName><ForeName>Federica</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neurology, Inselspital University Hospital Bern, 3010 Bern, Switzerland; Graduate School for Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scheidegger</LastName><ForeName>Olivier</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Neurology, Inselspital University Hospital Bern, 3010 Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oestmann</LastName><ForeName>Angelina</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Inselspital University Hospital Bern, 3010 Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hammond</LastName><ForeName>Jennetta W</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>Center for Neurotherapeutics Discovery, Departments of Neurology, Pediatrics, Neuroscience, and Microbiology and Immunology, University of Rochester, Rochester, NY 14618, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Herman</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Center for Neurotherapeutics Discovery, Departments of Neurology, Pediatrics, Neuroscience, and Microbiology and Immunology, University of Rochester, Rochester, NY 14618, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hyysalo</LastName><ForeName>Anu</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Biotechnology, University of Helsinki, 00790 Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peltola</LastName><ForeName>Roosa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute of Biotechnology, University of Helsinki, 00790 Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pattamatta</LastName><ForeName>Amrutha</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for NeuroGenetics, Department of Molecular Genetics and Microbiology, College of Medicine, Genetics Institute, University of Florida, Gainesville, FL 32610, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zu</LastName><ForeName>Tao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Center for NeuroGenetics, Department of Molecular Genetics and Microbiology, College of Medicine, Genetics Institute, University of Florida, Gainesville, FL 32610, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Voutilainen</LastName><ForeName>Merja H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Institute of Biotechnology, University of Helsinki, 00790 Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gelbard</LastName><ForeName>Harris A</ForeName><Initials>HA</Initials><AffiliationInfo><Affiliation>Center for Neurotherapeutics Discovery, Departments of Neurology, Pediatrics, Neuroscience, and Microbiology and Immunology, University of Rochester, Rochester, NY 14618, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saxena</LastName><ForeName>Smita</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Inselspital University Hospital Bern, 3010 Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ranum</LastName><ForeName>Laura P W</ForeName><Initials>LPW</Initials><AffiliationInfo><Affiliation>Center for NeuroGenetics, Department of Molecular Genetics and Microbiology, College of Medicine, Genetics Institute, University of Florida, Gainesville, FL 32610, USA; McKnight Brain Institute, Norman Fixel Institute for Neurological Disease, University of Florida, Gainesville, FL 32610, USA. Electronic address: ranum@ufl.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS098819</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R37 NS040389</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>10</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neuron</MedlineTA><NlmUniqueID>8809320</NlmUniqueID><ISSNLinking>0896-6273</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C565957">Amyotrophic Lateral Sclerosis 2, Juvenile</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042622" MajorTopicYN="N">DNA Repeat Expansion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS/FTD</Keyword><Keyword MajorTopicYN="N">C9orf72</Keyword><Keyword MajorTopicYN="N">FVB strain background</Keyword><Keyword MajorTopicYN="N">RAN proteins</Keyword><Keyword MajorTopicYN="N">microsatellite repeat</Keyword><Keyword MajorTopicYN="N">motor neuron disease</Keyword><Keyword MajorTopicYN="N">repeat associated non-AUG (RAN) translation</Keyword><Keyword MajorTopicYN="N">repeat expansion mutation</Keyword><Keyword MajorTopicYN="N">seizures</Keyword><Keyword MajorTopicYN="N">transgenic mouse models</Keyword></KeywordList><CoiStatement>Declaration of Interests L.P.W.R., T.Z., and L.N. are inventors on patents related to RAN translation filed by the University of Florida, and L.P.W.R. is a co-founder and director of RanTran, Inc.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>1</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>5</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>9</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>6</Day><Hour>20</Hour><Minute>10</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33022226</ArticleId><ArticleId IdType="mid">NIHMS1715564</ArticleId><ArticleId IdType="pmc">PMC8281452</ArticleId><ArticleId IdType="doi">10.1016/j.neuron.2020.09.009</ArticleId><ArticleId IdType="pii">S0896-6273(20)30709-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cleary EM, Pal S, Azam T, Moore DJ, Swingler R, Gorrie G, Stephenson L, Colville S, Chandran S, Porteous M, et al. (2016). Improved PCR based methods for detecting C9orf72 hexanucleotide repeat expansions. Mol Cell Probes 30, 218&#x2013;224.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4978699</ArticleId><ArticleId IdType="pubmed">27288208</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, Nicholson AM, Finch NA, Flynn H, Adamson J, et al. (2011). Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS. Neuron 72, 245&#x2013;256.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Faul F, Erdfelder E, Lang AG, and Buchner A (2007). G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39, 175&#x2013;191.</Citation><ArticleIdList><ArticleId IdType="pubmed">17695343</ArticleId></ArticleIdList></Reference><Reference><Citation>Gennarino VA, Singh RK, White JJ, De Maio A, Han K, Kim JY, Jafar-Nejad P, di Ronza A, Kang H, Sayegh LS, et al. (2015). Pumilio1 haploinsufficiency leads to SCA1-like neurodegeneration by increasing wild-type Ataxin1 levels. Cell 160, 1087&#x2013;1098.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4383046</ArticleId><ArticleId IdType="pubmed">25768905</ArticleId></ArticleIdList></Reference><Reference><Citation>Hennemann DE (2007). Diagnosis | &#x2018;Space cadet&#x2019; sydrome of female FVB/n mice. Lab Animal 36, 16.</Citation></Reference><Reference><Citation>Jiang J, Zhu Q, Gendron TF, Saberi S, McAlonis-Downes M, Seelman A, Stauffer JE, Jafar-Nejad P, Drenner K, Schulte D, et al. (2016). Gain of Toxicity from ALS/FTD-Linked Repeat Expansions in C9ORF72 Is Alleviated by Antisense Oligonucleotides Targeting GGGGCC-Containing RNAs. Neuron 90, 535&#x2013;550.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4860075</ArticleId><ArticleId IdType="pubmed">27112497</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohnken RA, and Schwahn DJ (2016). Lack of Chronic Histologic Lesions Supportive of Sublethal Spontaneous Seizures in FVB/N Mice. Comp Med 66, 105&#x2013;111.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4825959</ArticleId><ArticleId IdType="pubmed">27053564</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Pattamatta A, Zu T, Reid T, Bardhi O, Borchelt DR, Yachnis AT, and Ranum LP (2016). C9orf72 BAC Mouse Model with Motor Deficits and Neurodegenerative Features of ALS/FTD. Neuron 90, 521&#x2013;534.</Citation><ArticleIdList><ArticleId IdType="pubmed">27112499</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahler JF, Stokes W, Mann PC, Takaoka M, and Maronpot RR (1996). Spontaneous lesions in aging FVB/N mice. Toxicol Pathol 24, 710&#x2013;716.</Citation><ArticleIdList><ArticleId IdType="pubmed">8994298</ArticleId></ArticleIdList></Reference><Reference><Citation>Mordes D, Morrison BM, Ament XH, Cantrell C, Mok J, Eggan P, Xue C, Wang JY, Eggan K, and Rothstein JD (2020). Absence of survival and motor deficits in 500 repeat C9ORF72 BAC mice. Neuron (ADD CORRECT CITATION).</Citation><ArticleIdList><ArticleId IdType="pubmed">33022228</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen L, Montrasio F, Pattamatta A, Tusi SK, Bardhi O, Meyer KD, Hayes L, Nakamura K, Banez-Coronel M, Coyne A, et al. (2020). Antibody Therapy Targeting RAN Proteins Rescues C9 ALS/FTD Phenotypes in C9orf72 Mouse Model. Neuron 105, 645&#x2013;662 e611.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7391607</ArticleId><ArticleId IdType="pubmed">31831332</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Rourke JG, Bogdanik L, Muhammad AK, Gendron TF, Kim KJ, Austin A, Cady J, Liu EY, Zarrow J, Grant S, et al. (2015). C9orf72 BAC Transgenic Mice Display Typical Pathologic Features of ALS/FTD. Neuron 88, 892&#x2013;901.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4672384</ArticleId><ArticleId IdType="pubmed">26637796</ArticleId></ArticleIdList></Reference><Reference><Citation>Pattamatta A, Nguyen L, Olafson H, Scotti M, Laboissonniere LA, Richardson J, Berglund JA, Zu T, Wang ET, and Ranum LPW (2020). Repeat length increases disease penetrance and severity in C9orf72 ALS/FTD BAC transgenic mice. BioRxiv, doi: 10.1101/2020.1105.1121.107425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.1105.1121.107425</ArticleId><ArticleId IdType="pmc">PMC7906756</ArticleId><ArticleId IdType="pubmed">33378537</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters OM, Cabrera GT, Tran H, Gendron TF, McKeon JE, Metterville J, Weiss A, Wightman N, Salameh J, Kim J, et al. (2015). Human C9ORF72 Hexanucleotide Expansion Reproduces RNA Foci and Dipeptide Repeat Proteins but Not Neurodegeneration in BAC Transgenic Mice. Neuron 88, 902&#x2013;909.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4828340</ArticleId><ArticleId IdType="pubmed">26637797</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs JR, Schymick JC, Laaksovirta H, van Swieten JC, Myllykangas L, et al. (2011). A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD. Neuron 72, 257&#x2013;268.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenbaum MD, VandeWoude S, and Bielefeldt-Ohmann H (2007). Sudden onset of mortality within a colony of FVB/n mice. Lab Anim (NY) 36, 15&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">17519939</ArticleId></ArticleIdList></Reference><Reference><Citation>Schauwecker PE, Williams RW, and Santos JB (2004). Genetic control of sensitivity to hippocampal cell death induced by kainic acid: a quantitative trait loci analysis. J Comp Neurol 477, 96&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pubmed">15281082</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao Q, Liang C, Chang Q, Zhang W, Yang M, and Chen JF (2019). C9orf72 deficiency promotes motor deficits of a C9ALS/FTD mouse model in a dose-dependent manner. Acta Neuropathol Commun 7, 32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6398253</ArticleId><ArticleId IdType="pubmed">30832726</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoieb A, Allavena R, and Ibrahim A (2014). Neuronal necrosis due to a lethal epileptic syndrome affecting FVB strain B-actin luciferase transgenic mice. Amercan Journal of Animal and Veterinary Sciences 9, 189&#x2013;193.</Citation></Reference><Reference><Citation>Ward JM, Anver MR, Mahler JF, and Devor-Henneman DE (2000). Pathology of mice commonly used in genetic engineering (C57BL/6;129; B6, 129; and FVB/N). In Pathology of Genetically Engineered Mice, Ward JM, Mahler JF, Maronpot RR, and Sundberg JP, eds. (Ames Iowa: Iowa State University Press; ), pp. 161&#x2013;179.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>